glp-1 obesity drug news october 9 2025 Real-world studies of discontinuation showed that patients often regain weight at a significantly faster pace than after other weight-loss methods. At the same time, however, novel strategies aimed at countering those GLP-1 Agonists Weight Loss Drugs

The SURMOUNT-1 trial showed average weight loss of 20.9% at the 15 mg dose, with 57% of participants losing more than 20% of body weight

"If you can work that out and make a therapy that mimics that, that is what everyone wants: an injectable or oral medication that could mimic the surgery and cause weight loss in people without the surgery," she says

A cap on out-of-pocket medical expenses and coverage of all medically required treatments, including insulin medications, are mandated by German law for public insurance plans

To repair antigen, sections were microwaved for 15 min in EDTA, then immersed in 3% hydrogen peroxide to quench for endogenous peroxidase